1 completed, 1 terminated, 1 withdrawn. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Terminated 1, Withdrawn 1 |
| Phase 1 | 1 | Withdrawn 1 |
Follow apraglutide: new trials by email Literature Review of apraglutide trials Research Report on apraglutide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Proof-of-concept Trial of Apraglutide in Acute Graft Versus Host Disease (aGVHD) Apraglutide - GVHD | Phase 2 | Terminated | VectivBio AG | 31 | 2022-05-25 | 2025-10-20 |
| Metabolic Balance Study of Apraglutide in Patients With Short Bowel Syndrome, Intestinal Failure (SBS-IF) and Colon-in-Continuity (CIC) Apraglutide - Short Bowel Syndrome | Phase 2 | Completed | VectivBio AG | 10 | 2021-06-14 | 2025-06-18 |
| Safety, Tolerability, PK/PD of FE 203799 in Adults With Lymphomas FE 203799 - Lymphoma, Non-Hodgkin's, Adult, Lymphoma, Hodgkin's, Adult | Phase 1 / Phase 2 | Withdrawn | GlyPharma Therapeutics | 2018-09-01 | 2024-10-24 |
Graft vs Host Disease (1) · Hodgkin Disease (1) · Intestinal Failure (1) · Lymphoma (1) · Mucositis (1) · Short Bowel Syndrome (1)
VectivBio AG (2) · GlyPharma Therapeutics (1)
Belgium (1) · France (1) · Germany (1) · Portugal (1) · Spain (1) · United States (1)
Tomasz Masior (3)